Notes / Company

Syncom Formulations (India) Ltd.

SYNCOMF BSE 524470 ISIN INE312C01025 Pharmaceuticals

Fundamentals

Market cap: ₹1,347 cr
P/E: 19.55×
ROE: 14.45%
Debt / equity: 0.01
52-week range: 10.21 — 23.49

Research on Tijori Finance

The timeline — 1 note on Syncom Formulations (India) Ltd.

May 2026

22 May 26 · 18:35 IST Brief

Brief · Earnings

Syncom Formulations profit jumps 55% as revenue gains slow

Annual profit hit ₹76 crore on cost management, while fourth-quarter revenue contracted 10%.

Verify on exchange BSE filings for SYNCOMF NSE filings for SYNCOMF Tijori Finance company page